22 unchanged sentences
January 29, 2021
−Removed: Amended and Restated Director Compensation Policy
−Removed: February 25, 2022
+Added: License, Development and Commercialization Agreement, dated May 11, 2022, by and among the Registrant, Navire Pharma, Inc.
+Added: and Bristol-Myers Squibb Company.
+Added: Filed herewith
+Added: First Amendment to Loan and Security Agreement, dated May 12, 2022, among U.S.
+Added: Bank National Association in its capacity as Administrative Agent and Collateral Agent, the Lenders party thereto, the Registrant, and certain subsidiaries of the Registrant.
+Added: Filed herewith
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
22 unchanged sentences
Filed herewith
−Removed: # Indicates a management plan, contract or arrangement.
+Added: Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit in accordance with the rules of the Securities and Exchange Commission because such information (i) is not material and (ii) is the type that the Registrant treats as private or confidential.
* This certification will not be deemed “filed”
3 unchanged sentences
BridgeBio Pharma, Inc.
+Added: August 4, 2022
/s/ Neil Kumar
2 unchanged sentences
(Principal Executive Officer)
+Added: August 4, 2022
/s/ Brian Stephenson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.